Skip to main content
. 2021 Jul 8;12:671595. doi: 10.3389/fimmu.2021.671595

Figure 2.

Figure 2

Therapeutic targeting of CAFs. Four general approaches that target cancer-associated fibroblasts (CAFs) for cancer immunotherapy. DC, dendritic cell; Treg cell, regulatory T cell; MDSC, myeloid‐derived suppressor cell; ECM, extracellular matrix; CAR, chimeric antigen receptor.